Foundation Medicine Revenues Climb 87 Percent in Q4 2013 | GenomeWeb

NEW YORK (GenomeWeb News) – Foundation Medicine reported after the close of the market Tuesday that its fourth quarter revenues climbed 87 percent year over year and 18 percent over the previous quarter.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $9.7 million for the three months ended Dec. 31, up from $5.2 million in Q4 2012 and $8.2 million in Q3 2013. It beat the consensus Wall Street estimate of $9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.